ME01866B - Upotreba agomelatina za dobijanje ljekova namijenjenih liječenju periventrikularne leukomalacije - Google Patents

Upotreba agomelatina za dobijanje ljekova namijenjenih liječenju periventrikularne leukomalacije

Info

Publication number
ME01866B
ME01866B MEP-2010-503A MEP50310A ME01866B ME 01866 B ME01866 B ME 01866B ME P50310 A MEP50310 A ME P50310A ME 01866 B ME01866 B ME 01866B
Authority
ME
Montenegro
Prior art keywords
agomelatine
periventricular leukomalacia
obtain medication
treating
aimed
Prior art date
Application number
MEP-2010-503A
Other languages
English (en)
Inventor
Elisabeth Mocaer
Michael Spedding
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38229589&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ME01866(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Servier Lab filed Critical Servier Lab
Publication of ME01866B publication Critical patent/ME01866B/me

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MEP-2010-503A 2006-11-24 2007-11-23 Upotreba agomelatina za dobijanje ljekova namijenjenih liječenju periventrikularne leukomalacije ME01866B (me)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0610294A FR2908994B1 (fr) 2006-11-24 2006-11-24 Utilisation de l'agomelatine pour l'obtention de medicaments destines au traitement de la leucomalacie periventriculaire
EP07291392A EP1927351B1 (fr) 2006-11-24 2007-11-23 Utilisation de l'agomélatine pour l'obtention de médicaments destinés au traitement de la leucomalacie périventriculaire

Publications (1)

Publication Number Publication Date
ME01866B true ME01866B (me) 2011-04-30

Family

ID=38229589

Family Applications (1)

Application Number Title Priority Date Filing Date
MEP-2010-503A ME01866B (me) 2006-11-24 2007-11-23 Upotreba agomelatina za dobijanje ljekova namijenjenih liječenju periventrikularne leukomalacije

Country Status (38)

Country Link
US (1) US20080125493A1 (me)
EP (1) EP1927351B1 (me)
JP (1) JP4870062B2 (me)
KR (1) KR100976000B1 (me)
CN (1) CN101185644B (me)
AR (1) AR063895A1 (me)
AT (1) ATE483458T1 (me)
AU (1) AU2007234600B2 (me)
BR (1) BRPI0704179A (me)
CA (1) CA2610637C (me)
CL (1) CL2007003395A1 (me)
CY (1) CY1110875T1 (me)
DE (1) DE602007009627D1 (me)
DK (1) DK1927351T3 (me)
EA (1) EA014067B1 (me)
ES (1) ES2353128T3 (me)
FR (1) FR2908994B1 (me)
GE (1) GEP20094747B (me)
HK (1) HK1118216A1 (me)
HR (1) HRP20100680T1 (me)
JO (1) JO2631B1 (me)
MA (1) MA29522B1 (me)
ME (1) ME01866B (me)
MX (1) MX2007014004A (me)
MY (1) MY145925A (me)
NO (1) NO338598B1 (me)
NZ (1) NZ563683A (me)
PE (1) PE20081158A1 (me)
PL (1) PL1927351T3 (me)
PT (1) PT1927351E (me)
RS (1) RS51494B (me)
SG (1) SG143202A1 (me)
SI (1) SI1927351T1 (me)
TW (1) TW200829236A (me)
UA (1) UA94043C2 (me)
UY (1) UY30703A1 (me)
WO (1) WO2008071869A2 (me)
ZA (1) ZA200710102B (me)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2810656T3 (pl) 2013-06-06 2018-01-31 Zentiva Ks Preparaty agomelatyny zawierające agomelatynę w postaci kokryształów
EP2810647A1 (en) * 2013-06-06 2014-12-10 Zentiva, a.s. Pharmaceutical formulations comprising agomelatine in the form of agomelatine co-crystal with an organic acid

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2658818B1 (fr) 1990-02-27 1993-12-31 Adir Cie Nouveaux derives a structure naphtalenique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
US6921775B2 (en) * 2001-08-03 2005-07-26 Children's Medical Center Corporation Methods for modulating brain damage
FR2866335B1 (fr) * 2004-02-13 2006-05-26 Servier Lab Nouveau procede de synthese de l'agomelatine
US7358395B2 (en) * 2005-08-03 2008-04-15 Les Laboratories Servier Crystalline form V of agomelatine, a process for its preparation and pharmaceutical compositions containing it

Also Published As

Publication number Publication date
WO2008071869A2 (fr) 2008-06-19
PE20081158A1 (es) 2008-10-04
AR063895A1 (es) 2009-02-25
CN101185644B (zh) 2011-08-10
CA2610637C (fr) 2011-04-19
FR2908994A1 (fr) 2008-05-30
EP1927351A1 (fr) 2008-06-04
NO20076002L (no) 2008-05-26
MX2007014004A (es) 2009-02-16
KR20080047298A (ko) 2008-05-28
JP4870062B2 (ja) 2012-02-08
MY145925A (en) 2012-05-15
US20080125493A1 (en) 2008-05-29
TW200829236A (en) 2008-07-16
DK1927351T3 (da) 2011-01-10
CA2610637A1 (fr) 2008-05-24
DE602007009627D1 (de) 2010-11-18
GEP20094747B (en) 2009-07-27
AU2007234600A1 (en) 2008-06-12
SG143202A1 (en) 2008-06-27
AU2007234600B2 (en) 2012-05-17
CY1110875T1 (el) 2015-06-10
HRP20100680T1 (hr) 2011-01-31
JO2631B1 (en) 2012-06-17
WO2008071869A3 (fr) 2008-08-14
ES2353128T3 (es) 2011-02-25
MA29522B1 (fr) 2008-06-02
ATE483458T1 (de) 2010-10-15
CL2007003395A1 (es) 2008-09-12
CN101185644A (zh) 2008-05-28
FR2908994B1 (fr) 2009-04-03
ZA200710102B (en) 2008-11-26
NZ563683A (en) 2009-04-30
EA014067B1 (ru) 2010-08-30
RS51494B (en) 2011-04-30
AU2007234600A8 (en) 2010-12-02
UA94043C2 (ru) 2011-04-11
PL1927351T3 (pl) 2011-01-31
EP1927351B1 (fr) 2010-10-06
PT1927351E (pt) 2010-10-27
JP2008133279A (ja) 2008-06-12
KR100976000B1 (ko) 2010-08-17
EA200702317A1 (ru) 2008-06-30
HK1118216A1 (me) 2009-02-06
UY30703A1 (es) 2008-01-02
BRPI0704179A (pt) 2008-07-08
SI1927351T1 (sl) 2010-12-31
NO338598B1 (no) 2016-09-12

Similar Documents

Publication Publication Date Title
HK1127553A1 (en) Use of pegylated il-10 to treat cancer
GB0610867D0 (en) Treatment of pain
IL193460A0 (en) Compounds and methods for treatment of stroke
IL213068A0 (en) Pyridyloxyindoles inhibitors of vegf-r2 and use thereof for treatment of disease
IL193748A0 (en) Treatment of pain
IL194113A (en) Combinations of stroke treatment materials
PL1842535T3 (pl) Zastosowanie agomelatyny do otrzymywania leków przeznaczonych do leczenia uogólnionych zaburzeń lękowych
EP2182952A4 (en) TREATMENT OF POST-TRAUMATIC STRESS DISORDER
HRP20130544T1 (en) Long term treatment of hiv- infection with tcm278
HK1203160A1 (en) Tapentadol for the treatment of pain in arthrosis (tapentadol)
ZA200806808B (en) Treatment of stressed patients
IL213703A (en) Compounds for the treatment of pain and other diseases
GB0610868D0 (en) Treatment of pain
SI1929999T1 (sl) Uporaba agomelatina za izdelavo zdravila za zdravljenje sindroma Smith-Magenis
SI1927351T1 (sl) Uporaba agomelatina za pripravo zdravila za uporabo pri zdravljenju periventrikularne levkomalacije
EP2124950A4 (en) PAIN TREATMENT WITH NALOXONE
GB0616450D0 (en) Treatment of pain
GB0623740D0 (en) Treatment of disease
EP2219648A4 (en) TREATMENT OF POSTRAUMATIC STRESS WITH TETRAHYDROINDOLONE ARYLPIPERAZINE COMPOUNDS
GB0622471D0 (en) Use of reversine and analogs for treatment of cancer
GB0817859D0 (en) Treatment of proteostatic disease
GB0819543D0 (en) Treatment of proteostatic disease
GB0600237D0 (en) The treatment of pre-term labour